TTNP TITAN PHARMACEUTICALS INC Capital Structure Changes 8-K Filing 2023 - Notice from Nasdaq Titan Pharmaceuticals received notice from Nasdaq granting continued listing subject to compliance with stockholders equity and bid price requirements.Get access to all SEC 8-K filings of the TITAN PHARMACEUTICALS INC